Flapless Mini-incision Implant Surgery (NCT07008079) | Clinical Trial Compass
CompletedPhase 2
Flapless Mini-incision Implant Surgery
Saudi Arabia45 participantsStarted 2023-10-01
Plain-language summary
evaluate the clinical efficacy of the flapless mini-incision method compared to conventional flap and flapless punch methods
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients with adequate bone height and width at the site of implant 120 placement, and good quality bone to support a primary stability of at least 30 Ncm and D2 bone quality according to Lekholm and Zarb classification), based on preoperative radiographic assessment
* Clinical evidence of optimal periodontal health with no active periodontal disease in adjacent teeth
* No history of systemic illnesses that could affect bone health and wound heal- ing (e.g. uncontrolled diabetes mellitus, osteoporosis, renal osteodystrophy…etc.)
* No history of or requirement for bone grafting and augmentation at the implant site
* Willingness to participate in the study and attend prescribed follow-up appointments
Exclusion Criteria:
* Patients with history of radiation therapy for head and neck cancer
* Patients with history of allergy and hypersensitivity to local anesthetic agents, and biomaterials used in dental implants
* Pregnant women and lactating mothers
* History of smoking (\>2 cigarettes per day)
* Patients under treatment with anti-resorptive or anti-neoplastic medication such as bisphosphonates, chemotherapeutic agents, and monoclonal antibodies (e.g. Denosumab